Search company, investor...

Molecule

gomolecule.com

Stage

Incubator/Accelerator | Alive

About Molecule

Paloza, dba Molecule, provides technologies in the areas of smart polymer material, smart scavengers, chemical sensors, smart hydrogels, smart antimicrobial materials, smart control release and drug delivery materials, smart heavy metal scavengers and other smart functional materials. The company also provides custom synthesis of almost any organic compound.

Headquarters Location

725 San Aleso Ave Suite 3D

Sunnyvale, California, 94085,

United States

408-963-9222

Missing: Molecule's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Molecule's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Molecule Patents

Molecule has filed 9 patents.

The 3 most popular patent topics include:

  • Addition reactions
  • Organic redox reactions
  • Rearrangement reactions
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/10/2019

3/8/2022

Polymerization reactions, Polymer chemistry, Polymers, Thermoplastics, Substitution reactions

Grant

Application Date

10/10/2019

Grant Date

3/8/2022

Title

Related Topics

Polymerization reactions, Polymer chemistry, Polymers, Thermoplastics, Substitution reactions

Status

Grant

Latest Molecule News

Protein Tyrosine Phosphatase Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - ResearchAndMarkets.com

Dec 19, 2022

Protein Tyrosine Phosphatase (EC 3.1.3.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Protein Tyrosine Phosphatase (EC 3.1.3.48) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report analyses the pipeline products across relevant therapy areas under development and provides an overview of key players involved in Protein Tyrosine Phosphatase (EC 3.1.3.48) targeted therapeutics development and features dormant and discontinued projects. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The report is built using data and information sourced from the publisher proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Scope The report provides a snapshot of the Global therapeutic landscape for Protein Tyrosine Phosphatase (EC 3.1.3.48) The report reviews Protein Tyrosine Phosphatase (EC 3.1.3.48) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive Mechanism of Action (MoA), Research and Development (R&D) brief, Licensing and Collaboration details & Other Developmental Activities The report reviews key players involved in Protein Tyrosine Phosphatase (EC 3.1.3.48) targeted therapeutics and enlists all their major and minor projects The report assesses Protein Tyrosine Phosphatase (EC 3.1.3.48) targeted therapeutics based on Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type The report summarizes all the dormant and discontinued pipeline projects The report reviews latest news and deals related to Protein Tyrosine Phosphatase (EC 3.1.3.48) targeted therapeutics Reasons to Buy Gain strategically significant competitor information, analysis, and insights to formulate effective Research and Development (R&D) strategies Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Identify and understand the targeted therapy areas and indications for Protein Tyrosine Phosphatase (EC 3.1.3.48). Identify the use of drugs for target identification and drug repurposing Identify potential new clients or partners in the target demographic Develop strategic initiatives by understanding the focus areas of leading companies Plan Mergers and Acquisitions (M&A) effectively by identifying key players and it's most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Protein Tyrosine Phosphatase (EC 3.1.3.48) development landscape Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Key Topics Covered: Products under Development by Therapy Area Products under Development by Indication Products under Development by Companies Products under Development by Universities/Institutes Target - Therapeutics Assessment Assessment by Route of Administration Assessment by Molecule Type Company 1

Molecule Frequently Asked Questions (FAQ)

  • Where is Molecule's headquarters?

    Molecule's headquarters is located at 725 San Aleso Ave, Sunnyvale.

  • What is Molecule's latest funding round?

    Molecule's latest funding round is Incubator/Accelerator.

  • Who are the investors of Molecule?

    Investors of Molecule include Plug and Play Accelerator.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.